Article thumbnail

A Phase 1 Randomized, Open Label, Rectal Safety, Acceptability, Pharmacokinetic, and Pharmacodynamic Study of Three Formulations of Tenofovir 1% Gel (the CHARM-01 Study)

By Ian Mcgowan, Ross D. Cranston, Kathryn Duffill, Aaron Siegel, Jarret C. Engstrom, Alexyi Nikiforov, Cindy Jacobson, Khaja K. Rehman, Julie Elliott, Elena Khanukhova, Kaleab Abebe, Christine Mauck, Hans M. L. Spiegel, Charlene S. Dezzutti, Lisa C. Rohan, Mark A. Marzinke, Hiwot Hiruy, Craig W. Hendrix, Nicola Richardson-Harman, Peter A. Anton, Javier R. Lama, I McGowan, C Beyrer, JM Marrazzo, L Van Damme, RM Grant, KQ Abdool, PA Anton, LC Rohan, CS Dezzutti, I McGowan, CS Dezzutti, PA Anton, D Moher, KF Schulz, JL Schwartz, A van der Straten, K Geboes, I McGowan, KA Stoner, LK Rabe, CW Hendrix, JM Bland, J Nuttall, L Severy, PW Hunt, A Doleans-Jordheim, JJ Faith, N Richardson-Harman, NA Louissaint, CS Dezzutti, N Richardson-Harman and JH Herbst
Publisher: 'Public Library of Science (PLoS)'
DOI identifier: 10.1371/journal.pone.0125363
OAI identifier:
Provided by: Crossref
Sorry, our data provider has not provided any external links therefore we are unable to provide a link to the full text.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles